Legal Opinion
Mahaney ex rel. Estate of Kyle v. Novartis Pharmaceuticals Corp.
District Court, W.D. Kentucky
Decided December 14, 2011No. Case No. 1:06-CV-00035-RPublishedCited by 8 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
THOMAS B. RUSSELL, Senior District Judge.
This matter is set for trial on January 9, 2012. In anticipation of the final pretrial conference, the parties have filed a number of motions in limine. These motions have been fully briefed and are now ripe for adjudication. Below is the Court’s ruling on each of these matters.
I. BACKGROUND
Zometa and Aredia are two FDA-approved intravenous bisphosphonate (“IV BP”) drugs, manufactured by Defendant Novartis Pharmaceuticals Corporation (“NPC”). Both are used to combat a variety of advanced cancers that have presented…
2Cases cited36 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Luce v. United StatesSupreme Court of the United States · 1984
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- Tennant v. Peoria & Pekin Union Railway Co.Supreme Court of the United States · 1944
- United States v. John Ray Bonds (91-3610) Mark Verdi (91-3609) and Steven Wayne Yee (91-3608)Court of Appeals for the Sixth Circuit · 1994
31 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Charolette Payne v. Novartis Pharm. Corp.Court of Appeals for the Sixth Circuit · 2014
- Hill v. Novartis Pharmaceuticals Corp.District Court, E.D. California · 2013
- Deere & Co. v. FIMCO Inc.District Court, W.D. Kentucky · 2017
- Anderson v. United StatesDistrict Court, W.D. Kentucky · 2023
- Johns v. CR BardDistrict Court, S.D. Ohio · 2021
3 more not listed; retrieve them via the Exa API.